title: Quality of Life and Life Expectancy in Patients with Adrenal Insufficiency: What Is True and What Is Urban Myth?
abstract: For a long time it has been assumed that patients with chronic adrenal insufficiency under established replacement therapy have a normal life expectancy and a normal everyday life. Recent studies now indicate both an impairment of quality of life (QoL) with a negative impact on daily life and increased mortality in a significant number of patients. The clinical presentation of patients varies considerably. While some neither suffer from reduced QoL nor from adrenal crisis, others are significantly more affected by the disease. Long-term management of patients is thus more challenging and goes far beyond identification of the correct maintenance dose of corticosteroids. The mortality from adrenal crisis is still high and prevention should be a top priority for endocrinologists. Concepts of replacement therapy as well as patient education and emergency equipment are currently being reassessed. Developments to improve patient care and treatment comprise novel glucocorticoid preparations that are closer to the physiological circadian cortisol profile, a uniform European emergency card and more standardized crisis prevention measures.
authors.forename: Stephanie
authors.initials: S
authors.lastname: Burger-Stritt
authors.forename: Alina
authors.initials: A
authors.lastname: Pulzer
authors.forename: Stefanie
authors.initials: S
authors.lastname: Hahner
mesh_terms: D000309:Adrenal Insufficiency / Q000453:epidemiology* / Q000401:mortality; D006801:Humans; D008017:Life Expectancy; D011788:Quality of Life